{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:37Z","timestamp":1787041657294,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Skin Cancer Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cutaneous squamous cell carcinoma (cSCC) arises from epidermal keratinocytes and is the second most common epithelial malignancy. E74-like factor 5 (ELF5) is a member of the epithelium specific ETS subfamily of transcription factors and is essential for epithelial development, homeostasis and prevention of epithelial tumourigenesis. Transformation of keratinocytes involves the disruption of the progenitor differentiation program causing keratinocytes to fail to complete the process. This can lead to dysplastic epithelium and precancerous cells in skin. However, the precise mechanisms that causes the failure of keratinocytes to differentiate completely is not well understood. In our study, we discovered that ELF5 is abundantly expressed in healthy human skin (both basal and suprabasal layers), while its expression is lost in cSCC tissue biopsies. Using CRISPR-Cas9 knockout technology, functional studies along with transcript and protein analysis, loss of ELF5 in immortalised healthy keratinocytes leads to decreased ability of cells to differentiation and increased migration and tumourigenicity, in vitro. Overexpression of ELF5 leads to inhibition of cell migration and proliferation in keratinocytes and in cancer cell lines (A431 and SCC-9), in vitro. Further analysis using RNA transcriptomics has uncovered that GATA-3 and FLI-1 are potentially key molecular targets of ELF5 in keratinocytes. ELF5 regulation of both GATA-3 and FLI-1 is required to maintain the balance between healthy keratinocytes (proliferation\/differentiation) and to inhibit precancerous cell formation (tumourigenicity). Our data indicates that ELF5 plays an important role in potentially preventing transformation of keratinocytes and could suppresses skin tumourigenesis. However, additional studies are required to determine this, which could lead the targeting of ELF5 for future drug treatments in cSCC. Better understanding of the underlying mechanisms by which ELF5 regulates gene expression and consequently cell activity will provide new knowledge that can be translated into long-term benefits for patients with precancerous lesions to cSCC.<\/jats:p>","DOI":"10.1038\/s41598-026-59939-0","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:15:31Z","timestamp":1784175331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interplay of ELF5, GATA-3 and FLI-1 regulate malignant transformation of keratinocytes"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-9980","authenticated-orcid":false,"given":"Hetal. J.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-2540","authenticated-orcid":false,"given":"Maximilian. E.","family":"Pickup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8109-5960","authenticated-orcid":false,"given":"Maryam. A.","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8622-521X","authenticated-orcid":false,"given":"Chandrakala","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-7681","authenticated-orcid":false,"given":"Mohammed. I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"10","key":"59939_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers, H. W. et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 151(10), 1081\u20131086 (2015).","journal-title":"JAMA Dermatol."},{"issue":"3","key":"59939_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","volume":"155","author":"ZC Venables","year":"2019","unstructured":"Venables, Z. C. et al. Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England. JAMA Dermatol. 155(3), 298\u2013306 (2019).","journal-title":"JAMA Dermatol."},{"issue":"14","key":"59939_CR3","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1002\/cam4.4046","volume":"10","author":"W Zhang","year":"1990","unstructured":"Zhang, W. et al. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the global burden of disease study 2019. Cancer Med. 10(14), 4905\u20134922 (1990).","journal-title":"Cancer Med."},{"key":"59939_CR4","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04093","volume":"14","author":"S Huang","year":"1990","unstructured":"Huang, S. et al. Global burden and prediction study of cutaneous squamous cell carcinoma from 1990 to 2030: a systematic analysis and comparison with China. J. Glob. Health 14, 04093 (1990).","journal-title":"J. Glob. Health"},{"issue":"7","key":"59939_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41568-023-00583-5","volume":"23","author":"MCG Winge","year":"2023","unstructured":"Winge, M. C. G. et al. Advances in cutaneous squamous cell carcinoma. Nat. Rev. Cancer 23(7), 430\u2013449 (2023).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"59939_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ydbio.2008.04.038","volume":"320","author":"DE Metzger","year":"2008","unstructured":"Metzger, D. E., Stahlman, M. T. & Shannon, J. M. Misexpression of ELF5 disrupts lung branching and inhibits epithelial differentiation. Dev. Biol. 320(1), 149\u2013160 (2008).","journal-title":"Dev. Biol."},{"issue":"1","key":"59939_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13058-015-0666-0","volume":"18","author":"CL Piggin","year":"2016","unstructured":"Piggin, C. L. et al. ELF5 isoform expression is tissue-specific and significantly altered in cancer. Breast Cancer Res. BCR 18(1), 4\u20134 (2016).","journal-title":"Breast Cancer Res. BCR"},{"issue":"1","key":"59939_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ydbio.2017.02.007","volume":"424","author":"J Grassmeyer","year":"2017","unstructured":"Grassmeyer, J. et al. Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression. Dev. Biol. 424(1), 77\u201389 (2017).","journal-title":"Dev. Biol."},{"issue":"7","key":"59939_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/stem.1112","volume":"30","author":"R Chakrabarti","year":"2012","unstructured":"Chakrabarti, R. et al. Elf5 regulates mammary gland stem\/progenitor cell fate by influencing notch signaling. Stem Cells 30(7), 1496\u20131508 (2012).","journal-title":"Stem Cells"},{"issue":"10","key":"59939_CR10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/dev.136358","volume":"143","author":"MI Ahmed","year":"2016","unstructured":"Ahmed, M. I. et al. The transcriptional repressor Blimp1 is expressed in rare luminal progenitors and is essential for mammary gland development. Development 143(10), 1663\u20131673 (2016).","journal-title":"Development"},{"issue":"3","key":"59939_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jid.2022.06.028","volume":"143","author":"ME Pickup","year":"2023","unstructured":"Pickup, M. E. et al. MicroRNA-148a controls epidermal and hair follicle stem\/progenitor cells by modulating the activities of ROCK1 and ELF5. J. Invest. Dermatol. 143(3), 480-491.e5 (2023).","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"59939_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316134","volume":"20","author":"A Hu","year":"2025","unstructured":"Hu, A. et al. The involvement of Elf5 in regulating keratinocyte proliferation and differentiation processes in skin. PLoS ONE 20(1), e0316134 (2025).","journal-title":"PLoS ONE"},{"issue":"11","key":"59939_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ncb2607","volume":"14","author":"R Chakrabarti","year":"2012","unstructured":"Chakrabarti, R. et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat. Cell Biol. 14(11), 1212\u20131222 (2012).","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"59939_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41556-020-0495-y","volume":"22","author":"S Singh","year":"2020","unstructured":"Singh, S. et al. Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-\u03b3 signalling. Nat. Cell Biol. 22(5), 591\u2013602 (2020).","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"59939_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/pros.22970","volume":"75","author":"B Yao","year":"2015","unstructured":"Yao, B. et al. Elf5 inhibits TGF-\u03b2-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation. Prostate 75(8), 872\u2013882 (2015).","journal-title":"Prostate"},{"issue":"1","key":"59939_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.32831","volume":"147","author":"B Miao","year":"2020","unstructured":"Miao, B. et al. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation. Int. J. Cancer 147(1), 189\u2013201 (2020).","journal-title":"Int. J. Cancer"},{"issue":"12","key":"59939_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084324","volume":"8","author":"G Adhikary","year":"2013","unstructured":"Adhikary, G. et al. Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation. PLoS ONE 8(12), e84324 (2013).","journal-title":"PLoS ONE"},{"issue":"5830","key":"59939_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/293305a0","volume":"293","author":"GN Gill","year":"1981","unstructured":"Gill, G. N. & Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 293(5830), 305\u2013307 (1981).","journal-title":"Nature"},{"issue":"5967","key":"59939_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/309418a0","volume":"309","author":"A Ullrich","year":"1984","unstructured":"Ullrich, A. et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309(5967), 418\u2013425 (1984).","journal-title":"Nature"},{"issue":"1","key":"59939_CR20","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.1038\/s41598-023-35811-3","volume":"13","author":"C-Y Hsu","year":"2023","unstructured":"Hsu, C.-Y. et al. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft. Sci. Rep. 13(1), 8650 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"59939_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1101\/gad.1614608","volume":"22","author":"SR Oakes","year":"2008","unstructured":"Oakes, S. R. et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 22(5), 581\u2013586 (2008).","journal-title":"Genes Dev."},{"issue":"7","key":"59939_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/leu.2009.20","volume":"23","author":"JW Cui","year":"2009","unstructured":"Cui, J. W. et al. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia 23(7), 1311\u20131319 (2009).","journal-title":"Leukemia"},{"issue":"8","key":"59939_CR23","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/sj.onc.1202534","volume":"18","author":"R Pereira","year":"1999","unstructured":"Pereira, R. et al. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 18(8), 1597\u20131608 (1999).","journal-title":"Oncogene"},{"issue":"3","key":"59939_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.leu.2401689","volume":"14","author":"M Athanasiou","year":"2000","unstructured":"Athanasiou, M. et al. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia 14(3), 439\u2013445 (2000).","journal-title":"Leukemia"},{"issue":"40","key":"59939_CR25","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1038\/sj.onc.1202938","volume":"18","author":"KS Wong","year":"1999","unstructured":"Wong, K. S. et al. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. Oncogene 18(40), 5525\u20135534 (1999).","journal-title":"Oncogene"},{"issue":"4","key":"59939_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/cup.12667","volume":"43","author":"JF Solus","year":"2016","unstructured":"Solus, J. F. et al. Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining. J. Cutan. Pathol. 43(4), 347\u2013353 (2016).","journal-title":"J. Cutan. Pathol."},{"issue":"2","key":"59939_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/wrr.12142","volume":"22","author":"O Stojadinovic","year":"2014","unstructured":"Stojadinovic, O. et al. Deregulation of epidermal stem cell niche contributes to pathogenesis of nonhealing venous ulcers. Wound Repair Regen. 22(2), 220\u2013227 (2014).","journal-title":"Wound Repair Regen."},{"issue":"1","key":"59939_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2007.06.069","volume":"361","author":"A Chikh","year":"2007","unstructured":"Chikh, A. et al. Expression of GATA-3 in epidermis and hair follicle: relationship to p63. Biochem. Biophys. Res. Commun. 361(1), 1\u20136 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"59939_CR29","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1101\/gad.1115203","volume":"17","author":"CK Kaufman","year":"2003","unstructured":"Kaufman, C. K. et al. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 17(17), 2108\u20132122 (2003).","journal-title":"Genes Dev."},{"issue":"2","key":"59939_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00403-013-1435-5","volume":"306","author":"I Masse","year":"2014","unstructured":"Masse, I. et al. GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis. Arch. Dermatol. Res. 306(2), 201\u2013208 (2014).","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"59939_CR31","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.1038\/s41598-017-10252-x","volume":"7","author":"J Zeitvogel","year":"2017","unstructured":"Zeitvogel, J. et al. GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. Sci. Rep. 7(1), 11847 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"59939_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1186\/s12885-021-08604-y","volume":"21","author":"H Chen","year":"2021","unstructured":"Chen, H., Yang, J. & Wu, W. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma. BMC Cancer 21(1), 852 (2021).","journal-title":"BMC Cancer"},{"issue":"8","key":"59939_CR33","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1002\/cam4.1589","volume":"7","author":"X Yan","year":"2018","unstructured":"Yan, X. et al. Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells. Cancer Med. 7(8), 3548\u20133560 (2018).","journal-title":"Cancer Med."},{"key":"59939_CR34","volume":"99","author":"S Horibata","year":"2015","unstructured":"Horibata, S. et al. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J. Vis. Exp. 99, e52727 (2015).","journal-title":"J. Vis. Exp."},{"issue":"6","key":"59939_CR35","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1007\/s11033-021-06495-7","volume":"48","author":"X Qu","year":"2021","unstructured":"Qu, X. et al. ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24. Mol. Biol. Rep. 48(6), 5023\u20135032 (2021).","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"59939_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1375\/twin.14.4.316","volume":"14","author":"EJ Lapinskas","year":"2011","unstructured":"Lapinskas, E. J. et al. The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Twin Res. Hum. Genet. 14(4), 316\u2013322 (2011).","journal-title":"Twin Res. Hum. Genet."},{"issue":"1","key":"59939_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117510","volume":"10","author":"B Wu","year":"2015","unstructured":"Wu, B. et al. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer. PLoS ONE 10(1), e0117510 (2015).","journal-title":"PLoS ONE"},{"issue":"8","key":"59939_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/1940-6207.CAPR-20-0635","volume":"14","author":"M Miyano","year":"2021","unstructured":"Miyano, M. et al. Breast-specific molecular clocks comprised of ELF5 expression and promoter methylation identify individuals susceptible to cancer initiation. Cancer Prev. Res. 14(8), 779\u2013794 (2021).","journal-title":"Cancer Prev. Res."},{"key":"59939_CR39","doi-asserted-by":"crossref","unstructured":"Zhang, X., Lin, J., Ma, Y. & Zhao, J. Overexpression of E74-like factor 5 (ELF5) inhibits migration and invasion of ovarian cancer cells. Med. Sci. Monit. 30;25:856\u2013865 (2019).","DOI":"10.12659\/MSM.913058"},{"key":"59939_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114929","volume":"164","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. The roles, molecular interactions, and therapeutic value of CDK16 in human cancers. Biomed. Pharmacother. 164, 114929 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"5293","key":"59939_CR41","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr, C. J. Cancer cell cycles. Science 274(5293), 1672\u20131677 (1996).","journal-title":"Science"},{"issue":"1","key":"59939_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jcb.21978","volume":"106","author":"K Nishi","year":"2009","unstructured":"Nishi, K. et al. Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J. Cell. Biochem. 106(1), 63\u201372 (2009).","journal-title":"J. Cell. Biochem."},{"key":"59939_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000306","author":"RB Mertens","year":"2015","unstructured":"Mertens, R. B. et al. GATA3 expression in normal skin and in benign and malignant epidermal and cutaneous adnexal neoplasms. Am. J. Dermatopathol. https:\/\/doi.org\/10.1097\/DAD.0000000000000306 (2015).","journal-title":"Am. J. Dermatopathol."},{"issue":"4","key":"59939_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/jcb.200605057","volume":"175","author":"C de Guzman Strong","year":"2006","unstructured":"de Guzman Strong, C. et al. Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J. Cell Biol. 175(4), 661\u2013670 (2006).","journal-title":"J. Cell Biol."},{"issue":"2","key":"59939_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1242\/dev.02721","volume":"134","author":"D Kurek","year":"2007","unstructured":"Kurek, D. et al. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134(2), 261\u2013272 (2007).","journal-title":"Development"},{"key":"59939_CR46","doi-asserted-by":"crossref","unstructured":"Miettinen, M., et al., GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am. J. Surg. Pathol. 38(1) (2014).","DOI":"10.1097\/PAS.0b013e3182a0218f"},{"issue":"5","key":"59939_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019806","volume":"6","author":"E R\u00e1cz","year":"2011","unstructured":"R\u00e1cz, E. et al. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4. PLoS ONE 6(5), e19806 (2011).","journal-title":"PLoS ONE"},{"issue":"4","key":"59939_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000527382","volume":"90","author":"V Reiswich","year":"2023","unstructured":"Reiswich, V. et al. GATA3 expression in human tumors: a tissue microarray study on 16,557 tumors. Pathobiology 90(4), 219\u2013232 (2023).","journal-title":"Pathobiology"},{"key":"59939_CR49","doi-asserted-by":"crossref","unstructured":"Bota, E.C., et al., A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas. Monaldi Arch. Chest Dis. 94(2) (2023).","DOI":"10.4081\/monaldi.2023.2641"},{"issue":"1","key":"59939_CR50","doi-asserted-by":"publisher","first-page":"17795","DOI":"10.1038\/s41598-024-68788-8","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration. Sci. Rep. 14(1), 17795 (2024).","journal-title":"Sci. Rep."},{"issue":"4","key":"59939_CR51","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","volume":"87","author":"Y Ben-David","year":"1990","unstructured":"Ben-David, Y., Giddens, E. B. & Bernstein, A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 87(4), 1332\u20131336 (1990).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"59939_CR52","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1101\/gad.5.6.908","volume":"5","author":"Y Ben-David","year":"1991","unstructured":"Ben-David, Y. et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5(6), 908\u2013918 (1991).","journal-title":"Genes Dev."},{"issue":"6","key":"59939_CR53","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1128\/MCB.19.6.4452","volume":"19","author":"A Tamir","year":"1999","unstructured":"Tamir, A. et al. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the rb gene during differentiation. Mol. Cell. Biol. 19(6), 4452\u20134464 (1999).","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"59939_CR54","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/emboj\/21.4.694","volume":"21","author":"I Lesault","year":"2002","unstructured":"Lesault, I. et al. Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1-transformed erythroblasts. EMBO J. 21(4), 694 (2002).","journal-title":"EMBO J."},{"issue":"16","key":"59939_CR55","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/onc.2014.162","volume":"34","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. The ets transcription factor Fli-1 in development, cancer and disease. Oncogene 34(16), 2022\u20132031 (2015).","journal-title":"Oncogene"},{"key":"59939_CR56","doi-asserted-by":"crossref","unstructured":"Ahmed, M. I., et al. Interplay of microRNA-21 and Satb1 in epidermal keratinocytes during skin aging. J. Investig. Dermatol. (2019).","DOI":"10.1016\/j.jid.2019.04.022"},{"issue":"12","key":"59939_CR57","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/jid.2015.317","volume":"135","author":"AA Alase","year":"2015","unstructured":"Alase, A. A. et al. IFN\u03bb stimulates MxA production in human dermal fibroblasts a MAPK-dependent STAT1-independent mechanism. J. Investig. Dermatol. 135(12), 2935\u20132943 (2015).","journal-title":"J. Investig. Dermatol."},{"issue":"3","key":"59939_CR58","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106(3), 761\u2013771 (1988).","journal-title":"J. Cell Biol."},{"issue":"5","key":"59939_CR59","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors2. JNCI J. Natl. Cancer Inst. 51(5), 1417\u20131423 (1973).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"5","key":"59939_CR60","first-page":"1657","volume":"41","author":"JG Rheinwald","year":"1981","unstructured":"Rheinwald, J. G. & Beckett, M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Can. Res. 41(5), 1657\u20131663 (1981).","journal-title":"Can. Res."},{"issue":"12","key":"59939_CR61","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1016\/j.jid.2019.04.022","volume":"139","author":"MI Ahmed","year":"2019","unstructured":"Ahmed, M. I. et al. Interplay of MICRORNA-21 and SATB1 in epidermal keratinocytes during skin aging. J. Invest Dermatol. 139(12), 2538-2542.e2 (2019).","journal-title":"J. Invest Dermatol."},{"issue":"4","key":"59939_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402\u2013408 (2001).","journal-title":"Methods"},{"issue":"1","key":"59939_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1), 15\u201321 (2013).","journal-title":"Bioinformatics"},{"issue":"9","key":"59939_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215495","volume":"14","author":"LJ Gearing","year":"2019","unstructured":"Gearing, L. J. et al. CiiiDER: a tool for predicting and analysing transcription factor binding sites. PLoS ONE 14(9), e0215495 (2019).","journal-title":"PLoS ONE"},{"issue":"22","key":"59939_CR65","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1242\/dev.070284","volume":"138","author":"AN Mardaryev","year":"2011","unstructured":"Mardaryev, A. N. et al. Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development 138(22), 4843\u20134852 (2011).","journal-title":"Development"},{"issue":"4","key":"59939_CR66","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3892\/etm.2021.9797","volume":"21","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. MicroRNA-185 inhibits the proliferation and migration of HaCaT keratinocytes by targeting peroxisome proliferator-activated receptor \u03b2. Exp Ther Med 21(4), 366 (2021).","journal-title":"Exp Ther Med"},{"issue":"5","key":"59939_CR67","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ijc.2910030517","volume":"3","author":"M Stoker","year":"1968","unstructured":"Stoker, M. et al. Anchorage and growth regulation in normal and virus-transformed cells. Int. J. Cancer 3(5), 683\u2013693 (1968).","journal-title":"Int. J. Cancer"},{"issue":"10","key":"59939_CR68","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-05-4158","volume":"66","author":"Q Ren","year":"2006","unstructured":"Ren, Q. et al. Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor \u03baB signaling. Can. Res. 66(10), 5209\u20135215 (2006).","journal-title":"Can. Res."},{"key":"59939_CR69","volume":"92","author":"S Borowicz","year":"2014","unstructured":"Borowicz, S. et al. The soft agar colony formation assay. J. Vis. Exp. 92, e51998 (2014).","journal-title":"J. Vis. Exp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59939-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:34Z","timestamp":1787040154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59939-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59939-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25881"}}